SCHEMBL29680396

SCHEMBL29680396

Oc1cc2ccccc2c(O)c1F

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPM4 Q8TD43 1/20 0.56
PTPN22 Q9Y2R2 1/20 0.50
NQO2 P16083 1/20 0.48
PTPN1 P18031 1/20 0.43
CYP1A2 P05177 1/20 0.43
CASP6 P55212 1/20 0.43
NQO1 P15559 1/20 0.42
ALOX5 P09917 1/20 0.41
L3MBTL1 Q9Y468 2/20 0.40
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
NPC1 O15118 1/20 0.40
RAB9A P51151 1/20 0.40
ALDH1A1 P00352 2/20 0.39
HIF1A Q16665 1/20 0.39
CYP1B1 Q16678 1/20 0.39
HSD17B10 Q99714 1/20 0.39
MAPT P10636 2/20 0.39
IDO1 P14902 1/20 0.39
THRB P10828 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL631989 1.00 TRPM4 (0.56) TRPM4PTPN22NQO2PTPN1CYP1A2
SCHEMBL31258857 0.84 TRPM4 (0.58) TRPM4PTPN22NQO2PTPN1CYP1A2
SCHEMBL4247740 0.83 PTPN22 (0.45) TRPM4PTPN22NQO2CYP1A2CASP6
SCHEMBL30151482 0.79 TRPM4 (0.62) TRPM4PTPN22NQO2CYP1A2CASP6
SCHEMBL27738 0.79 TRPM4 (0.62) TRPM4PTPN22NQO2CYP1A2CASP6
SCHEMBL28159001 0.79 TRPM4 (0.62) TRPM4PTPN22NQO2CYP1A2CASP6
SCHEMBL11298208 0.79 PTPN22 (0.42) TRPM4PTPN22NQO2CYP1A2CASP6
SCHEMBL29344183 0.79 CYP1A2 (0.45) TRPM4PTPN22NQO2CYP1A2CASP6
SCHEMBL24857744 0.79 TRPM4 (0.52) TRPM4PTPN22NQO2PTPN1CYP1A2
SCHEMBL16646896 0.79 TRPM4 (0.52) TRPM4PTPN22NQO2PTPN1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4262807-A1 AZAQUINAZOLINE PAN-KRAS INHIBITORS Mirati Therapeutics, Inc. (US) 2023-10-25 EP disclosed
CN-112204036-B Macrocyclic fused pyrazoles as MCL-1 inhibitors 苏州亚盛药业有限公司 2022-12-27 CN disclosed
WO-2022132200-A1 AZAQUINAZOLINE PAN-KRAS INHIBITORS Mirati Therapeutics, Inc. (US) 2022-06-23 WO disclosed